Knowledge Center
Presentation / Oct 17, 2021
Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures
Source:
AAPS 2021
Track: Formulation and Delivery – Chemical
Rapid Fire: Role of Excipients in Formulation & Drug Product Development (CE)
|
Presenting Author: Ricardo Gonçalves - Analytical Scientist, R&D Analytical Development
Why do we use small lactose particles to improve Dry Powder Inhaler formulations? Why sieved and milled lactose particles present different properties? This presentation explores the role of surface energetics, measured using inverse gas chromatography, in the behavior of DPI formulations and the implication on their aerodynamic performance.
Also in the Knowledge Center
/ Jan 01, 2006
Process for preparation of fluticasone analogs via esterification of a carbothioic acid
Read more
Scientific Article
/ Jan 01, 2002
Process for the preparation of flumethasone and its 17-carboxyl-androstene analog
Read more
Scientific Article
/ Jan 01, 2002
Crystallization process for the preparation of crystalline and solvent-free iohexol
Read more
Scientific Article